CytoReason
- Biotech or pharma, therapeutic R&D
- IT, information
- Digital health
Probability of efficacy success is the #1 factor in return on R&D investment. CytoReason's computational models support pharma companies in transforming R&D into predictable practice with solutions in target/combo prioritization, indication selection, and patient stratification.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}